Goldman Sachs Upgrades Varian Medical (VAR) to Neutral on Stabilization

March 7, 2013 7:28 AM EST Send to a Friend
Get Alerts VAR Hot Sheet
Price: $84.91 -0.09%

Rating Summary:
    14 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 13 | New: 28
Trade VAR Now!
Join SI Premium – FREE
Goldman Sachs upgraded Varian Medical (NYSE: VAR) from Sell to Neutral with a price target of $79.00 (from $62.00).

The firm sees business fundamentals stabilizing and said consensus estimates are now reasonable. The radiation oncology market operating dynamics look to be reaching a bottom, according to the firm.

Goldman raised FY13 EPS from $4.09 to $4.10, FY14 from $4.57 to $4.80 and FY15 from $5.07 to $5.37.

For an analyst ratings summary and ratings history on Varian Medical click here. For more ratings news on Varian Medical click here.

Shares of Varian Medical closed at $72.01 yesterday.




You May Also Be Interested In


Related Categories

Analyst EPS Change, Analyst PT Change, Upgrades

Related Entities

Goldman Sachs

Add Your Comment